ZM - Lazy investing
With vaccines being approved and distributed, stocks such as Zoom and Peloton will have a strong correction in the coming quarter but will have a good future ahead. Both have competitors from tech giants.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。